Alpine Associates Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Alpine Associates Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,005,600	Closed	-$96.3M	–	49
2020 Q1	$96.3M	Sell	2,005,600 -110,000	-5%	-$5.12M	3.83%	10
2019 Q4	$99.3M	Buy	+2,115,600	New	+$93.5M	3.16%	13

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Alpine Associates Management's RARX Position: Q2 2020 in Review

Alpine Associates Management sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 2,005,600 shares — an estimated $96.3M sold.

Alpine Associates Management first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $99.3M in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Alpine Associates Management reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Alpine Associates Management sold 2,005,600 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $96.3M.
Alpine Associates Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Alpine Associates Management's Ra Pharmaceuticals, Inc. Common Stock position peaked at $99.3M in Q4 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Alpine Associates Management's 13F filing for Q2 2020, filed 12 Aug 2020.